Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting2
Enrolling by invitation1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting250%
enrolling_by_invitation125%
not_yet_recruiting125%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

NCT07618936
enrolling_by_invitation

Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage

NCT03253835
recruiting

FAPI PET/CT in Various FAP-Related Disease Patients

NCT06688071
not_yet_recruitingnot_applicable

Tbit System Precision and Correlation of Different Blood Samples

NCT04478812

Clinical Trials (4)

Showing 4 of 4 trials
NCT07618936

Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients

Recruiting
NCT03253835

Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage

Enrolling By Invitation
NCT06688071

FAPI PET/CT in Various FAP-Related Disease Patients

Recruiting
NCT04478812Not Applicable

Tbit System Precision and Correlation of Different Blood Samples

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4